Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes

被引：35
|
作者：
Preiser, Jean-Charles [1 ]
Provenzano, Bruna [1 ]
Mongkolpun, Wasineeart [1 ]
Halenarova, Katarina [1 ]
Cnop, Miriam [2 ,3 ]
机构：
[1] Free Univ Brussels, Dept Intens Care, Brussels, Belgium
[2] Free Univ Brussels, Erasmus Hosp, Div Endocrinol, Brussels, Belgium
[3] Free Univ Brussels, Ctr Diabet Res, Brussels, Belgium
来源：
ANESTHESIOLOGY | 2020年 / 133卷 / 02期
关键词：
COTRANSPORTER-2; INHIBITORS; CARDIOVASCULAR EVENTS; LACTIC-ACIDOSIS; BLOOD-GLUCOSE; METFORMIN; HYPERGLYCEMIA; DEATH; RISK; MORTALITY; SURGERY;
D O I：
10.1097/ALN.0000000000003237
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：430 / 438
页数：9
相关论文
共 50 条
  • [11] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Kalyani, Rita R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1248 - 1260
  • [12] Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
    Ferrannini, Ele
    DeFronzo, Ralph A.
    EUROPEAN HEART JOURNAL, 2015, 36 (34) : 2288 - U19
  • [13] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Donnelly, Peter E.
    Winch, Denis E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07): : 670 - 671
  • [14] Glucose-lowering medicines for type 2 diabetes
    Davoren, Peter
    AUSTRALIAN FAMILY PHYSICIAN, 2015, 44 (05) : 272 - 276
  • [15] The dawn phenomenon in type 2 diabetes: its association with glucose excursions and changes after oral glucose-lowering drugs
    Wang, Jun-Sing
    Lee, I-Te
    Lee, Wen-Jane
    Lin, Shi-Dou
    Su, Shih-Li
    Tu, Shih-Te
    Lin, Shih-Yi
    Sheu, Wayne Huey-Herng
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [16] Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes
    Tomlinson, Brian
    Hu, Miao
    Zhang, Yuzhen
    Chan, Paul
    Liu, Zhong-Min
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (11) : 1267 - 1271
  • [17] Glucose-Lowering Drugs and Risk of COPD Exacerbations in Adults with Type 2 Diabetes
    Ray, Avik
    Paik, Julie M.
    Feldman, William B.
    Sreedhara, Sushama Kattinakere
    Wexler, Deborah J.
    Patorno, Elisabetta
    DIABETES, 2024, 73
  • [18] Use of glucose-lowering drugs and risk of fracture in patients with type 2 diabetes
    Starup-Linde, Jakob
    Gregersen, Soren
    Frost, Morten
    Vestergaard, Peter
    BONE, 2017, 95 : 136 - 142
  • [19] Cardiovascular Outcomes Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes
    Gerstein, Hertzel C.
    Shah, Reema
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 97 - +
  • [20] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes REPLY
    Kalyani, Rita R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07): : 671 - 672
12345